VectorY | EUVC

This website uses cookies

Read our Privacy policy and Terms of use for more information.

VectorY

VectorY

Forbion's history in the development of gene therapies

1 min read

Forbion's history in the development of gene therapies

The science and strategy behind three FDA gene therapies in 2022

Feb 1, 2023

Our investment approach for companies developing precision treatments for rare diseases

1 min read

Our investment approach for companies developing precision treatments for rare diseases

Investing in precision therapies for rare disease companies

Feb 1, 2023